News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

APT Starts Human Trials Of Aerosolized Hydroxychloroquine For Asthma


10/19/2005 5:10:06 PM

APT Pharmaceuticals is beginning clinical studies of aerosolized hydroxychloroquine (AHCQ) for treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), rhinitis and severe acute respiratory syndrome (SARS).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES